Results 71 to 80 of about 158,005 (297)

New perspectives in treating high-risk cardiac patients. Rosuvastain and it’s perspectives for clinical practice use

Кардиоваскулярная терапия и профилактика, 2007
The review summarizes modern principles of lipid-lowering therapy aimed at cardiovascular event risk reduction. The author describes main patient groups in need for early, aggressive lipid-lowering therapy – predominantly, statin therapy.
M. G. Bubnova
doaj  

THE DIFFERENTIATED LIPID-LOWERING THERAPY IN WOMEN WITH CORONARY HEART DISEASE IN MENOPAUSE

Евразийский Кардиологический Журнал, 2012
The aim of the study: to assess the impact of differentiated lipid-lowering therapy on lipid metabolism, immune and inflammatory changes in women with stable angina in menopause.
N. A. Manak, O. A. Barbuk
doaj   +1 more source

Selection of medication in hospitalised elderly patients with Angina Pectoris [PDF]

, 2004
Objective: To evaluate medication changes in hospitalised elderly patients diagnosed with angina pectoris and to compare the selection of medication with evidence-based treatment guidelines. Design: Review of medical notes and patient interview. Setting:
Gauci, Marise, McElnay, James C., Cacciottolo, Joseph M.   +2 more
core  

Blood Biomarkers and Surface‐Enhanced Raman Spectroscopy for Gout: A Comprehensive Review

Advanced Functional Materials, EarlyView.
Schematic illustrating gout disease progression from asymptomatic hyperuricemia to chronic tophaceous disease, highlighting the limitations of conventional imaging and biochemical diagnostics and the potential of engineered SERS platforms for ultrasensitive blood‐based detection of urate‐related biomarkers across disease stages, with the color gradient
Isuri Perera, Chiranjeevi Kanike, Appurva Tiwari, Hongyan Wu, Larry D. Unsworth, Ben Bin Xu, Xuehua Zhang   +6 more
wiley   +1 more source

Role of imaging techniques in the assessment of vulnerable plaques and the effectiveness of lipid-lowering therapy

Российский кардиологический журнал
The aim was to evaluate the potential of various imaging methods in the diagnosis of vulnerable coronary plaques and their stabilization using various lipid-lowering therapy regimens.The sources were searched in the PubMed database using the following ...
G. R. Bikbaeva, A. N. Kovalskaya, K. V. Kuznetsova, T. V. Pavlova, D. V. Duplyakov   +4 more
doaj   +1 more source

Aptamer‐Based Delivery Systems for VEGF and NGF Modulation in Ocular Therapies

Advanced Healthcare Materials, EarlyView.
Aptamer‐based delivery systems targeting NGF and VEGF hold significant potential for precise and sustained treatment of complex diseases affecting both the anterior and posterior segments of the eye. This review critically summarizes current strategies for NGF and VEGF delivery as well as VEGF sequestration, providing a clinical perspective on how ...
Nadine Best, Gizem Karabiyik, Gerd Geerling, Sarah Barbara Zwingelberg, Gregor Lang, Martin Humenik   +5 more
wiley   +1 more source

The “Chinese Dose” of statin

Cardiology Plus, 2016
The benefits of atherosclerotic cardiovascular disease prevention/treatment and lipid-lowering therapy come from the reduction of cholesterol itself. However, based on safety considerations, all guidelines note that high-intensity statin therapy is not ...
Ping Ye
doaj   +1 more source

The problem of safety of lipid-lowering therapy

Kardiologiia, 2019
This study focused on analysis of current publications evaluating safety of lipid-lowering therapy. Search for literature was performed on websites of cardiological societies and online databases, including PubMed, EMBASE, and eLibrary by the following key words: statins, statin intolerance, lipid-lowering therapy, statin safety, and statin аdverse ...
openaire   +3 more sources

One‐Step Microfluidic Manufactured Fucose‐Decorated Sweetosomes Choose the Time and the Road for Their Intracellular Journey to Cancer Treatment

Advanced Healthcare Materials, EarlyView.
Sweetosomes, a new class of fucose‐decorated liposomes, are developed via a one‐step microfluidic process without surface chemistry. This study elucidates their main caveolae‐mediated entry and distinct endosomal trafficking. These nanostructures demonstrate superior endosomal escape, organelle acidity modulation, and prolonged plasma persistence ...
Mattia Tiboni, Mariele Montanari, Shiva Khorshid, Michele Verboni, Andrea Duranti, Simone Lucarini, Daniele Lopez, Annalisa Aluigi, Gianluca Morganti, Michele Menotta, Giovanna Panza, Daniel J. Klionsky, Barbara Canonico, Luca Casettari   +13 more
wiley   +1 more source

Insufficient lipid-lowering therapy in the treatment of patients after acute coronary syndrome – there is room for improvement in the PCSK9 inhibitor era

Cardiologia Hungarica
Although the beneficial morbidity and mortality effects of lipid-lowering treatment have been demonstrated in numerous clinical trials, there is a significant gap between the guidelines and daily practice.
Gergely György Nagy, László Márk, Norbert Kiss, Andrea Gerencsér, György Rokszin, Ibolya Fábián, Dániel Aradi, László Bajnok, Zoltán Csanádi, István Karádi, István Reiber, György Paragh   +11 more
doaj   +1 more source